Stuart E Dryer Selected Research

Hyperhomocysteinemia

10/2015

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart E Dryer Research Topics

Disease

7	Segmental glomerulosclerosis 01/2022 - 05/2014
6	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2024 - 08/2013
6	Kidney Diseases (Kidney Disease) 11/2022 - 05/2014
6	Fibrosis (Cirrhosis) 11/2022 - 01/2018
5	Diabetic Nephropathies (Diabetic Nephropathy) 11/2022 - 09/2011
5	Glomerulonephritis 11/2022 - 08/2014
3	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 10/2021
3	Albuminuria 01/2022 - 01/2018
3	Ureteral Obstruction 01/2022 - 03/2019
3	Body Weight (Weight, Body) 12/2019 - 10/2016
3	Chronic Renal Insufficiency 03/2019 - 04/2014
2	Proteinuria 01/2023 - 03/2019
2	Inflammation (Inflammations) 01/2021 - 03/2019
2	Nephrosis 01/2018 - 10/2015
1	Infections 01/2024
1	Channelopathies 01/2023
1	Ischemia 11/2022
1	Dyslipidemias (Dyslipidemia) 12/2019
1	Hyperglycemia 12/2019
1	Weight Gain 12/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Disease Progression 01/2019
1	Azotemia 01/2018
1	Hyperhomocysteinemia 10/2015
1	Wounds and Injuries (Trauma) 02/2015
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2010
1	Melanoma (Melanoma, Malignant) 09/2007
1	Hypoxia (Hypoxemia) 03/2003

Drug/Important Bio-Agent (IBA)

10	TRPC6 Cation ChannelIBA 11/2022 - 10/2010
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2024 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	VimentinIBA 01/2021 - 03/2019
2	NitrogenIBA 12/2019 - 03/2019
2	Urea (Carbamide)FDA LinkGeneric 12/2019 - 03/2019
2	CreatinineIBA 12/2019 - 03/2019
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2018 - 01/2017
2	Puromycin AminonucleosideIBA 01/2018 - 10/2015
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2016 - 10/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2024
1	Pattern Recognition ReceptorsIBA 01/2024
1	IntegrinsIBA 01/2024
1	Monomeric GTP-Binding ProteinsIBA 01/2023
1	Ion Channels (Ion Channel)IBA 01/2023
1	C-PeptideIBA 12/2019
1	Streptozocin (Streptozotocin)FDA Link 12/2019
1	nephrinIBA 12/2019
1	Immunoglobulin G (IgG)IBA 03/2019
1	Complement System Proteins (Complement)IBA 03/2019
1	CholesterolIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	AlbuminsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Dizocilpine Maleate (Dizocilpine)IBA 10/2016
1	N-Methylaspartate (NMDA)IBA 10/2016
1	Memantine (Namenda)FDA Link 10/2016
1	statticIBA 02/2015
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	Angiotensin IIIBA 04/2014
1	NPHS2 proteinIBA 08/2013
1	Transient Receptor Potential ChannelsIBA 08/2013
1	Insulin (Novolin)FDA Link 09/2011
1	Estrogen Receptor alphaIBA 08/2011
1	Potassium Channels (Potassium Channel)IBA 08/2011
1	Estrogen ReceptorsIBA 08/2011
1	Tamoxifen FDA LinkGeneric 08/2011
1	Estrogens (Estrogen)FDA Link 08/2011
1	FilaminsIBA 09/2007
1	Sodium-Activated Potassium ChannelsIBA 03/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2015
1	Therapeutics 08/2011